Keywords: داروی amphiphilic کاتیونی; Brimonidine; Phospholipidosis; α2 adrenergic agonist; α2 adrenergic antagonist; Meibomian gland dysfunction; Dry eye disease; phosphoinositide 3-kinase-protein kinase B; AKT; bovine pituitary extract; BPE; cationic amphiphilic drug; CAD; adenosine 3,5-c
مقالات ISI داروی amphiphilic کاتیونی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: داروی amphiphilic کاتیونی; AFM; Atomic force microscope; CAD; Cationic amphiphilic drug; CLSM; Confocal laser scanning microscope; DIP; Drug induced phospholipidosis; GO; Graphene oxide; IND; Investigational new drug; LOPAC; Library of Pharmacologically Active Compounds; NBD-PE; N-
Hydrophilic interaction chromatography with a focus on the drug-phosphate interaction in drug screening to determine the phospholipidosis induction risk
Keywords: داروی amphiphilic کاتیونی; CAD; cationic amphiphilic drug; DIPL; drug-induced phospholipidosis; HCl; hydrochloric acid; HILIC; hydrophilic interaction chromatography; NaCl; sodium chloride; RP-HPLC; reversed-phase high-performance liquid chromatography; Tris; tris(hydroxymethyl)ami
Keywords: داروی amphiphilic کاتیونی; Cholesterol transfer of NPC2; Regulation of acid sphingomyelinase; Tay Sachs disease; Regulation of ganglioside catabolism; Lipid modifiers; ASM; acid sphingomyelinase; BMP; bis(monoacylglycero)-phosphate; CAD; cationic amphiphilic drug; DOPC; dioleoyl-l-
Keywords: داروی amphiphilic کاتیونی; BMP; bis(monoacylglycero)phosphate; CAD; cationic amphiphilic drug; DIP; drug induced phospholipidosis; GXVPLA2; group XV phospholipase A2; LPLA2; lysosomal phospholipase A2; MDCK; Madin Darby canine kidney; PDMP; d-threo-1-phenyl-2-decanoylamino-3-morpho
Cellular accumulation and lipid binding of perfluorinated alkylated substances (PFASs) - A comparison with lysosomotropic drugs
Keywords: داروی amphiphilic کاتیونی; Bioaccumulation; Perfluorinated compounds; PFOS; Cationic amphiphilic drugs; Adipocytes; Phospholipid binding; ACC; compound's accumulation in cells; ACE; acetaminophen; ACN; acetonitrile; AMIO; amiodarone; AMIT; amitriptyline; AZI; azithromycin; AZAG; az
Computational identification of a phospholipidosis toxicophore using 13C and 15N NMR-distance based fingerprints
Keywords: داروی amphiphilic کاتیونی; 3D-SDAR; three-dimensional spectral data-activity relationship; AM1; Austin model 1; CAD; cationic amphiphilic drug; FDA; food and drug administration; PLD; phospholipidosis; PLS-DA; partial least squares-discriminant analysis; PLWG; phospholipidosis
A fluorogenic phospholipid for the detection of lysosomal phospholipase A2 activity
Keywords: داروی amphiphilic کاتیونی; Phospholipase A2; Phosphatidylgycerol; Lysosome; Phospholipidosis; Cationic amphiphilic drug; Amiodarone; Fluoxetine; Fluorophore;
Comparison of a genomic and a multiplex cell imaging approach for the detection of phospholipidosis
Keywords: داروی amphiphilic کاتیونی; AUC; area under the concentration-time curve from 0 to 24 h; ANIT; α-naphthyl-isothiocyanate; BNF; β-naphthoflavone; CAD; cationic amphiphilic drug; Cmax; maximum concentration; DMSO; dimethylsulfoxide; EM; electron microscopy; FDA; Food and Drug Admin
High content screening analysis of phospholipidosis: Validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis
Keywords: داروی amphiphilic کاتیونی; BCS; bovine calf serum; CAD; cationic amphiphilic drug; DMEM⧹HAM F12; Dulbecco's Modified Eagles Medium Nutrient Mixture F-12; DMSO; dimethyl sulfoxide; LOEL; lowest observed effect level; NBD-PE; N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-dihexadecano
Prediction of phospholipidosis-inducing potential of drugs by in vitro biochemical and physicochemical assays followed by multivariate analysis
Keywords: داروی amphiphilic کاتیونی; Drug-induced phospholipidosis; Cationic amphiphilic drug; Principal component analysis; Phospholipid vesicle; Rat liver microsome; Phospholipase A2; pKa; Partition coefficient
Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes
Keywords: داروی amphiphilic کاتیونی; Drug-induced phospholipidosis; Cationic amphiphilic drug; Mannose 6-phosphate/IGF-II receptor; Lysosomal enzymes; Endosomes
Drug-induced phospholipidosis
Keywords: داروی amphiphilic کاتیونی; Drug-induced phospholipidosis; Lysosome; Cationic amphiphilic drug; Lamellar body